War In Gaza Forces Israel To Delay Medical Cannabis Reform
Portfolio Pulse from Jelena Martinovic
The Israel Ministry of Health has postponed the implementation of medical cannabis regulatory reform by three months due to the Israel-Hamas war. The reform, which aims to ease restrictions and improve patient access, is expected to boost Israel's medical cannabis exports. IM Cannabis Corp. (NASDAQ:IMCC), the first Israeli cannabis company on NASDAQ, remains optimistic about the reform's future impact. Meanwhile, Israel has seen a surge in medical cannabis patients, particularly post-war, with a record increase in November 2023.
December 08, 2023 | 6:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IM Cannabis Corp. (NASDAQ:IMCC) anticipates the delayed Israeli medical cannabis reform to positively impact the market and patient access, potentially boosting the company's future prospects.
IM Cannabis Corp. is directly involved in the Israeli medical cannabis market and stands to benefit from the regulatory reform. The delay is a temporary setback, but the company's optimistic outlook suggests a positive impact on its operations and potential for growth once the reform is implemented.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90